ApoE facilitates the microglial response to amyloid plaque pathology
One of the hallmarks of Alzheimer's disease is the presence of extracellular diffuse and fibrillar plaques predominantly consisting of the amyloid-β (Aβ) peptide. Apolipoprotein E (ApoE) influences the deposition of amyloid pathology through affecting the clearance and aggregation of monomeric...
Saved in:
Published in | The Journal of experimental medicine Vol. 215; no. 4; pp. 1047 - 1058 |
---|---|
Main Authors | , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Rockefeller University Press
02.04.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | One of the hallmarks of Alzheimer's disease is the presence of extracellular diffuse and fibrillar plaques predominantly consisting of the amyloid-β (Aβ) peptide. Apolipoprotein E (ApoE) influences the deposition of amyloid pathology through affecting the clearance and aggregation of monomeric Aβ in the brain. In addition to influencing Aβ metabolism, increasing evidence suggests that apoE influences microglial function in neurodegenerative diseases. Here, we characterize the impact that apoE has on amyloid pathology and the innate immune response in APPPS1ΔE9 and APPPS1-21 transgenic mice. We report that
deficiency reduced fibrillar plaque deposition, consistent with previous studies. However, fibrillar plaques in
-deficient mice exhibited a striking reduction in plaque compaction. Hyperspectral fluorescent imaging using luminescent conjugated oligothiophenes identified distinct Aβ morphotypes in
-deficient mice. We also observed a significant reduction in fibrillar plaque-associated microgliosis and activated microglial gene expression in
-deficient mice, along with significant increases in dystrophic neurites around fibrillar plaques. Our results suggest that apoE is critical in stimulating the innate immune response to amyloid pathology. |
---|---|
AbstractList | One of the hallmarks of Alzheimer’s disease is the presence of extracellular diffuse and fibrillar plaques predominantly consisting of the amyloid-β (Aβ) peptide. Apolipoprotein E (ApoE) influences the deposition of amyloid pathology through affecting the clearance and aggregation of monomeric Aβ in the brain. In addition to influencing Aβ metabolism, increasing evidence suggests that apoE influences microglial function in neurodegenerative diseases. Here, we characterize the impact that apoE has on amyloid pathology and the innate immune response in APPPS1ΔE9 and APPPS1-21 transgenic mice. We report that Apoe deficiency reduced fibrillar plaque deposition, consistent with previous studies. However, fibrillar plaques in Apoe-deficient mice exhibited a striking reduction in plaque compaction. Hyperspectral fluorescent imaging using luminescent conjugated oligothiophenes identified distinct Aβ morphotypes in Apoe-deficient mice. We also observed a significant reduction in fibrillar plaque–associated microgliosis and activated microglial gene expression in Apoe-deficient mice, along with significant increases in dystrophic neurites around fibrillar plaques. Our results suggest that apoE is critical in stimulating the innate immune response to amyloid pathology. Increasing evidence suggests that apoE influences the innate immune response in neurodegeneration. Here, Ulrich et al. report that apoE influences amyloid plaque morphology and the microglial response to amyloid plaques, along with plaque-associated neuronal toxicity.One of the hallmarks of Alzheimer’s disease is the presence of extracellular diffuse and fibrillar plaques predominantly consisting of the amyloid-β (Aβ) peptide. Apolipoprotein E (ApoE) influences the deposition of amyloid pathology through affecting the clearance and aggregation of monomeric Aβ in the brain. In addition to influencing Aβ metabolism, increasing evidence suggests that apoE influences microglial function in neurodegenerative diseases. Here, we characterize the impact that apoE has on amyloid pathology and the innate immune response in APPPS1ΔE9 and APPPS1-21 transgenic mice. We report that Apoe deficiency reduced fibrillar plaque deposition, consistent with previous studies. However, fibrillar plaques in Apoe-deficient mice exhibited a striking reduction in plaque compaction. Hyperspectral fluorescent imaging using luminescent conjugated oligothiophenes identified distinct Aβ morphotypes in Apoe-deficient mice. We also observed a significant reduction in fibrillar plaque–associated microgliosis and activated microglial gene expression in Apoe-deficient mice, along with significant increases in dystrophic neurites around fibrillar plaques. Our results suggest that apoE is critical in stimulating the innate immune response to amyloid pathology. One of the hallmarks of Alzheimer's disease is the presence of extracellular diffuse and fibrillar plaques predominantly consisting of the amyloid-β (Aβ) peptide. Apolipoprotein E (ApoE) influences the deposition of amyloid pathology through affecting the clearance and aggregation of monomeric Aβ in the brain. In addition to influencing Aβ metabolism, increasing evidence suggests that apoE influences microglial function in neurodegenerative diseases. Here, we characterize the impact that apoE has on amyloid pathology and the innate immune response in APPPS1ΔE9 and APPPS1-21 transgenic mice. We report that deficiency reduced fibrillar plaque deposition, consistent with previous studies. However, fibrillar plaques in -deficient mice exhibited a striking reduction in plaque compaction. Hyperspectral fluorescent imaging using luminescent conjugated oligothiophenes identified distinct Aβ morphotypes in -deficient mice. We also observed a significant reduction in fibrillar plaque-associated microgliosis and activated microglial gene expression in -deficient mice, along with significant increases in dystrophic neurites around fibrillar plaques. Our results suggest that apoE is critical in stimulating the innate immune response to amyloid pathology. Increasing evidence suggests that apoE influences the innate immune response in neurodegeneration. Here, Ulrich et al. report that apoE influences amyloid plaque morphology and the microglial response to amyloid plaques, along with plaque-associated neuronal toxicity. One of the hallmarks of Alzheimer’s disease is the presence of extracellular diffuse and fibrillar plaques predominantly consisting of the amyloid-β (Aβ) peptide. Apolipoprotein E (ApoE) influences the deposition of amyloid pathology through affecting the clearance and aggregation of monomeric Aβ in the brain. In addition to influencing Aβ metabolism, increasing evidence suggests that apoE influences microglial function in neurodegenerative diseases. Here, we characterize the impact that apoE has on amyloid pathology and the innate immune response in APPPS1ΔE9 and APPPS1-21 transgenic mice. We report that Apoe deficiency reduced fibrillar plaque deposition, consistent with previous studies. However, fibrillar plaques in Apoe -deficient mice exhibited a striking reduction in plaque compaction. Hyperspectral fluorescent imaging using luminescent conjugated oligothiophenes identified distinct Aβ morphotypes in Apoe -deficient mice. We also observed a significant reduction in fibrillar plaque–associated microgliosis and activated microglial gene expression in Apoe -deficient mice, along with significant increases in dystrophic neurites around fibrillar plaques. Our results suggest that apoE is critical in stimulating the innate immune response to amyloid pathology. One of the hallmarks of Alzheimers disease is the presence of extracellular diffuse and fibrillar plaques predominantly consisting of the amyloid-beta (A beta) peptide. Apolipoprotein E (ApoE) influences the deposition of amyloid pathology through affecting the clearance and aggregation of monomeric A beta in the brain. In addition to influencing A beta metabolism, increasing evidence suggests that apoE influences microglial function in neurodegenerative diseases. Here, we characterize the impact that apoE has on amyloid pathology and the innate immune response in APPPS1 Delta E9 and APPPS1-21 transgenic mice. We report that Apoe deficiency reduced fibrillar plaque deposition, consistent with previous studies. However, fibrillar plaques in Apoe-deficient mice exhibited a striking reduction in plaque compaction. Hyperspectral fluorescent imaging using luminescent conjugated oligothiophenes identified distinct A beta morphotypes in Apoe-deficient mice. We also observed a significant reduction in fibrillar plaque-associated microgliosis and activated microglial gene expression in Apoe-deficient mice, along with significant increases in dystrophic neurites around fibrillar plaques. Our results suggest that apoE is critical in stimulating the innate immune response to amyloid pathology. |
Author | Song, Wilbur M Nilsson, K Peter Anderson, Elise Jiang, Hong Nyström, Sofie Zhou, Yingyue Ulland, Tyler K Choi, Seulah Reinartz, Mariska Colonna, Marco Ulrich, Jason D Wang, Yaming Mahan, Thomas E Holtzman, David M Stewart, Floy R |
AuthorAffiliation | 1 Department of Neurology, Washington University School of Medicine, St. Louis, MO 2 Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, MO 3 Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO 4 Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 5 Department of Chemistry, IFM, Linköping University, Linköping, Sweden 6 Radboud University Nijmegen, Nijmegen, Netherlands 7 Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN |
AuthorAffiliation_xml | – name: 6 Radboud University Nijmegen, Nijmegen, Netherlands – name: 7 Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN – name: 3 Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO – name: 1 Department of Neurology, Washington University School of Medicine, St. Louis, MO – name: 5 Department of Chemistry, IFM, Linköping University, Linköping, Sweden – name: 2 Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, MO – name: 4 Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO |
Author_xml | – sequence: 1 givenname: Jason D surname: Ulrich fullname: Ulrich, Jason D organization: Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO – sequence: 2 givenname: Tyler K orcidid: 0000-0002-6507-4989 surname: Ulland fullname: Ulland, Tyler K organization: Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO – sequence: 3 givenname: Thomas E surname: Mahan fullname: Mahan, Thomas E organization: Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO – sequence: 4 givenname: Sofie orcidid: 0000-0002-4303-4783 surname: Nyström fullname: Nyström, Sofie organization: Department of Chemistry, IFM, Linköping University, Linköping, Sweden – sequence: 5 givenname: K Peter surname: Nilsson fullname: Nilsson, K Peter organization: Department of Chemistry, IFM, Linköping University, Linköping, Sweden – sequence: 6 givenname: Wilbur M orcidid: 0000-0002-6608-4628 surname: Song fullname: Song, Wilbur M organization: Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO – sequence: 7 givenname: Yingyue surname: Zhou fullname: Zhou, Yingyue organization: Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO – sequence: 8 givenname: Mariska orcidid: 0000-0001-7964-7963 surname: Reinartz fullname: Reinartz, Mariska organization: Radboud University Nijmegen, Nijmegen, Netherlands – sequence: 9 givenname: Seulah surname: Choi fullname: Choi, Seulah organization: Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO – sequence: 10 givenname: Hong surname: Jiang fullname: Jiang, Hong organization: Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO – sequence: 11 givenname: Floy R surname: Stewart fullname: Stewart, Floy R organization: Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO – sequence: 12 givenname: Elise surname: Anderson fullname: Anderson, Elise organization: Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO – sequence: 13 givenname: Yaming surname: Wang fullname: Wang, Yaming organization: Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN – sequence: 14 givenname: Marco orcidid: 0000-0001-5222-4987 surname: Colonna fullname: Colonna, Marco email: mcolonna@pathology.wustl.edu organization: Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO mcolonna@pathology.wustl.edu – sequence: 15 givenname: David M orcidid: 0000-0002-3400-0856 surname: Holtzman fullname: Holtzman, David M email: holtzman@neuro.wustl.edu organization: Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29483128$$D View this record in MEDLINE/PubMed https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-150505$$DView record from Swedish Publication Index |
BookMark | eNpdkTtP5DAUhS3ECoZHR40i0WxB2GvHTuwGacRzJaRtFlrLCTczHjlxsBPQ_Pv1aADByoULf_f4nHsOyG7veyTkhMIFBcl_rbC7YEArykqxQ2ZUcMiVKOQumQEwllOAap8cxLgCoJyLco_sM8VlQZmckev54G-y1jTW2dGMGLNxiVlnm-AXzhqXBYyD7yNmo89Mt3bePmeDMy8TZoMZl975xfqI_GiNi3j8fh-Sx9ubv1f3-cOfu99X84e8EbQcc1Ur5IWqK1UJIZMTxgpOUdRlayTlpULKq9aYGhoKVKm2kRXjlUAjBC_Kujgk-VY3vuEw1XoItjNhrb2x-to-zbUPC-3spKmAdBJ_ueUT3OFzg_0YjPs29v2lt0u98K9ayI0fngR-vgsEnxLHUXc2Nuic6dFPUTMAKaXY_nX2H7ryU-jTOhLFgFcpyoY631JpvzEGbD_NUNCbOnWqU3_UmfDTrwE-4Y_-in9AQpxR |
CitedBy_id | crossref_primary_10_1186_s13024_018_0303_3 crossref_primary_10_3389_fncel_2021_749587 crossref_primary_10_1016_j_nbd_2019_02_015 crossref_primary_10_2967_jnumed_119_227322 crossref_primary_10_3389_fnins_2024_1326784 crossref_primary_10_1007_s12035_021_02477_9 crossref_primary_10_1177_10738584211040786 crossref_primary_10_3390_ijms23105404 crossref_primary_10_1016_j_neuron_2021_03_024 crossref_primary_10_1515_tjb_2020_0135 crossref_primary_10_1016_j_immuni_2019_03_016 crossref_primary_10_1016_j_neurobiolaging_2024_03_007 crossref_primary_10_1002_cbic_202300044 crossref_primary_10_1146_annurev_genet_112618_043515 crossref_primary_10_1016_j_neuron_2024_01_013 crossref_primary_10_1002_alz_13780 crossref_primary_10_1186_s13024_022_00588_y crossref_primary_10_3389_fnagi_2022_888989 crossref_primary_10_3389_fnagi_2023_1158579 crossref_primary_10_1016_j_isci_2024_110006 crossref_primary_10_1016_j_jneuroim_2024_578342 crossref_primary_10_1038_s41593_018_0296_9 crossref_primary_10_1186_s13024_019_0337_1 crossref_primary_10_1038_s41577_023_00837_1 crossref_primary_10_1016_j_tins_2022_01_002 crossref_primary_10_1002_alz_13703 crossref_primary_10_3389_fimmu_2020_00754 crossref_primary_10_1007_s11064_018_2629_1 crossref_primary_10_3389_fnins_2018_00963 crossref_primary_10_1016_S1474_4422_20_30412_9 crossref_primary_10_1093_braincomms_fcab126 crossref_primary_10_1038_s41593_024_01669_5 crossref_primary_10_1016_j_jlr_2023_100350 crossref_primary_10_1126_scitranslmed_abc9375 crossref_primary_10_1002_chem_202203568 crossref_primary_10_1093_nar_gkae100 crossref_primary_10_1007_s00401_020_02200_3 crossref_primary_10_1002_glia_24105 crossref_primary_10_1016_j_isci_2023_106375 crossref_primary_10_1016_j_nbas_2022_100055 crossref_primary_10_3390_ph14050458 crossref_primary_10_1016_j_it_2020_07_006 crossref_primary_10_1126_scitranslmed_adj9052 crossref_primary_10_3390_ijms242417377 crossref_primary_10_7554_eLife_54083 crossref_primary_10_3390_ijms22042033 crossref_primary_10_1017_S1431927621012095 crossref_primary_10_3389_fnagi_2023_1201982 crossref_primary_10_1126_sciadv_abk0473 crossref_primary_10_1186_s13024_024_00734_8 crossref_primary_10_1364_OE_390874 crossref_primary_10_3390_biomedicines10040840 crossref_primary_10_1126_scitranslmed_aay3069 crossref_primary_10_1177_1073858420987224 crossref_primary_10_1038_s41593_022_01127_0 crossref_primary_10_1038_s41590_018_0212_1 crossref_primary_10_1016_j_bbalip_2022_159123 crossref_primary_10_1016_j_jconrel_2021_08_018 crossref_primary_10_1093_gerona_glz262 crossref_primary_10_1038_s41582_019_0228_7 crossref_primary_10_3233_JAD_190711 crossref_primary_10_4103_1673_5374_355747 crossref_primary_10_1007_s00018_023_04784_x crossref_primary_10_1186_s13024_019_0351_3 crossref_primary_10_1093_jnen_nlab085 crossref_primary_10_1016_j_arr_2020_101212 crossref_primary_10_1016_j_celrep_2019_03_099 crossref_primary_10_1186_s12974_023_02823_9 crossref_primary_10_1186_s13024_022_00574_4 crossref_primary_10_1002_jnr_24718 crossref_primary_10_1016_j_ijbiomac_2022_01_115 crossref_primary_10_1038_s43587_021_00054_2 crossref_primary_10_1001_jamanetworkopen_2019_13909 crossref_primary_10_1038_s43587_023_00491_1 crossref_primary_10_3389_fnagi_2018_00395 crossref_primary_10_1186_s40478_019_0840_1 crossref_primary_10_3390_ijms241310809 crossref_primary_10_1016_j_neuron_2022_10_022 crossref_primary_10_1016_j_neuron_2022_10_021 crossref_primary_10_2967_jnumed_120_261858 crossref_primary_10_1186_s13195_023_01209_6 crossref_primary_10_1016_j_nicl_2019_101767 crossref_primary_10_1186_s13024_023_00610_x crossref_primary_10_1177_10738584211070273 crossref_primary_10_3390_biom10101439 crossref_primary_10_1002_alz_12375 crossref_primary_10_1016_j_neulet_2019_134285 crossref_primary_10_1002_JLB_MR0818_319R crossref_primary_10_1002_alz_12256 crossref_primary_10_1038_s41577_018_0051_1 crossref_primary_10_3390_genes12081247 crossref_primary_10_1016_j_cell_2020_05_003 crossref_primary_10_1084_jem_20200474 crossref_primary_10_1186_s13024_022_00566_4 crossref_primary_10_1016_j_cell_2019_09_001 crossref_primary_10_1186_s13024_020_00413_4 crossref_primary_10_3389_fncel_2018_00397 crossref_primary_10_1007_s12035_022_03082_0 crossref_primary_10_1002_ibra_12155 crossref_primary_10_1186_s12974_020_01948_5 crossref_primary_10_1073_pnas_2218915120 crossref_primary_10_3390_ijms20010081 crossref_primary_10_1016_j_nbd_2022_105967 crossref_primary_10_1177_20406223221081605 crossref_primary_10_1186_s13024_018_0296_y crossref_primary_10_1007_s12035_024_04143_2 crossref_primary_10_3389_fnins_2021_778822 crossref_primary_10_3390_cells9071717 crossref_primary_10_3389_fnins_2021_666958 crossref_primary_10_1186_s40478_021_01298_0 crossref_primary_10_15252_emmm_201910606 crossref_primary_10_2147_ITT_S455881 crossref_primary_10_2174_1567205017666200212155234 crossref_primary_10_1186_s13024_022_00577_1 crossref_primary_10_1016_j_neurobiolaging_2018_11_008 crossref_primary_10_1186_s13024_022_00516_0 crossref_primary_10_3390_ijms21072381 crossref_primary_10_1111_imr_12896 crossref_primary_10_1016_j_neuroscience_2023_01_032 crossref_primary_10_1038_s43587_021_00123_6 crossref_primary_10_1186_s13024_023_00599_3 crossref_primary_10_1186_s40478_019_0729_z crossref_primary_10_1038_s41467_024_48484_x crossref_primary_10_1016_j_apsb_2021_10_002 crossref_primary_10_1016_j_immuni_2022_10_016 crossref_primary_10_1084_jem_20180653 crossref_primary_10_1186_s13024_023_00679_4 crossref_primary_10_3389_fphar_2019_00840 crossref_primary_10_1080_17460441_2020_1674808 crossref_primary_10_1007_s00018_021_03810_0 crossref_primary_10_3389_fneur_2018_01062 crossref_primary_10_1016_j_saa_2023_123743 crossref_primary_10_1038_s41591_018_0336_8 crossref_primary_10_1016_j_neulet_2019_134306 crossref_primary_10_1084_jem_20212479 crossref_primary_10_1016_j_celrep_2020_107530 crossref_primary_10_1016_j_ejphar_2021_173873 crossref_primary_10_1016_j_biopha_2022_114127 crossref_primary_10_3389_fncel_2019_00063 crossref_primary_10_1016_j_neuron_2022_03_004 crossref_primary_10_1186_s40478_020_01075_5 crossref_primary_10_1016_j_pbiomolbio_2023_06_002 crossref_primary_10_1111_nan_12529 crossref_primary_10_1186_s40478_021_01261_z crossref_primary_10_1172_JCI131564 crossref_primary_10_1002_adma_201806701 crossref_primary_10_1002_chem_202201557 crossref_primary_10_1016_j_smim_2022_101594 crossref_primary_10_1038_s41590_023_01640_9 crossref_primary_10_3390_cells10040957 crossref_primary_10_1002_anbr_202100097 crossref_primary_10_1186_s12864_022_08417_8 crossref_primary_10_1186_s13024_023_00645_0 crossref_primary_10_3389_fnmol_2020_609073 crossref_primary_10_1016_j_it_2024_03_007 crossref_primary_10_1007_s00018_021_03986_5 crossref_primary_10_1186_s13024_018_0298_9 crossref_primary_10_1007_s00401_022_02467_8 crossref_primary_10_2174_1574885518666230427100702 crossref_primary_10_3390_ijms25063090 crossref_primary_10_1002_jnr_24526 crossref_primary_10_1016_j_neurobiolaging_2022_03_011 crossref_primary_10_1016_j_neuron_2020_10_008 crossref_primary_10_3233_JAD_240042 crossref_primary_10_1038_s41551_022_00906_1 crossref_primary_10_1073_pnas_2114486119 crossref_primary_10_3233_JAD_231210 crossref_primary_10_1111_jnc_14674 crossref_primary_10_3233_JAD_230002 |
Cites_doi | 10.1002/cbic.201200731 10.1038/nature11087 10.1038/ncomms7176 10.1038/nn.3697 10.1177/002215540004800906 10.1172/JCI36663 10.1126/science.1227901 10.1016/j.neuron.2017.11.014 10.1038/nature24016 10.1038/sj.jcbfm.9600419 10.1097/NEN.0b013e3182933788 10.1016/j.biopsych.2017.03.003 10.1016/j.cell.2017.05.018 10.1038/ncomms11295 10.1172/JCI6179 10.1039/c1ob05637a 10.1186/1742-2094-11-111 10.1002/1531-8249(200006)47:6<739::AID-ANA6>3.0.CO;2-8 10.1152/ajpcell.00563.2005 10.1186/1750-1326-9-20 10.1074/jbc.M115.679043 10.1016/j.cell.2017.07.023 10.1371/journal.pone.0021880 10.1038/ng.801 10.1093/hmg/ddh019 10.1016/j.neuron.2013.04.014 10.1016/j.jalz.2016.07.004 10.1073/pnas.96.26.15233 10.1038/sj.embor.7400784 10.1016/j.immuni.2017.08.008 10.1534/genetics.105.051912 10.1016/j.cell.2015.01.049 10.1056/NEJMoa1211851 10.1021/cb4000376 10.1016/j.jneuroim.2014.03.010 10.1073/pnas.1609896113 10.1038/nn.3599 10.1016/0165-5728(93)90027-V 10.1126/science.294.5545.1354 10.1038/nn.4018 10.1038/ni.3102 10.1038/ng1197-263 10.1016/j.neuron.2017.11.013 10.1016/j.neuron.2016.06.015 10.1016/0304-3940(95)11763-M 10.4161/pri.29239 10.1056/NEJMoa1211103 10.1038/nm.3913 10.1007/s004010000263 10.1006/nbdi.2002.0483 10.1016/j.neuron.2016.05.003 10.1002/ana.24304 10.4049/jimmunol.173.10.6366 10.1523/JNEUROSCI.2110-16.2016 10.1084/jem.20151948 10.1194/jlr.R075481 |
ContentType | Journal Article |
Copyright | 2018 Ulrich et al. Copyright Rockefeller University Press Apr 2, 2018 2018 Ulrich et al. 2018 |
Copyright_xml | – notice: 2018 Ulrich et al. – notice: Copyright Rockefeller University Press Apr 2, 2018 – notice: 2018 Ulrich et al. 2018 |
DBID | NPM AAYXX CITATION 7QL 7QP 7T5 7TK 7U9 8FD C1K FR3 H94 M7N P64 RC3 7X8 5PM ABXSW ADTPV AOWAS D8T DG8 ZZAVC |
DOI | 10.1084/jem.20171265 |
DatabaseName | PubMed CrossRef Bacteriology Abstracts (Microbiology B) Calcium & Calcified Tissue Abstracts Immunology Abstracts Neurosciences Abstracts Virology and AIDS Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database AIDS and Cancer Research Abstracts Algology Mycology and Protozoology Abstracts (Microbiology C) Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) SWEPUB Linköpings universitet full text SwePub SwePub Articles SWEPUB Freely available online SWEPUB Linköpings universitet SwePub Articles full text |
DatabaseTitle | PubMed CrossRef Genetics Abstracts Virology and AIDS Abstracts Technology Research Database Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts Immunology Abstracts Engineering Research Database Calcium & Calcified Tissue Abstracts Neurosciences Abstracts Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | CrossRef Genetics Abstracts PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
DocumentTitleAlternate | ApoE and microglia activation in amyloid models |
EISSN | 1540-9538 |
EndPage | 1058 |
ExternalDocumentID | oai_DiVA_org_liu_150505 10_1084_jem_20171265 29483128 |
Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NIA NIH HHS grantid: R01 AG047644 – fundername: NIA NIH HHS grantid: RF1 AG051485 – fundername: NCI NIH HHS grantid: T32 CA009547 – fundername: ; – fundername: Donors Cure Foundation grantid: CCAD201703 – fundername: ; grantid: 5-T32CA009547-30 – fundername: ; grantid: AG047644 – fundername: ; grantid: RF1AG05148501 |
GroupedDBID | --- -~X 18M 29K 2WC 36B 4.4 53G 5GY 5RE 5VS ABOCM ABZEH ACGFO ACNCT ACPRK ADBBV AENEX AFOSN AFRAH ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BTFSW C45 CS3 D-I DIK DU5 E3Z EBS EJD F5P F9R FRP GX1 H13 HYE IH2 K-O KQ8 L7B N9A NPM O5R O5S OK1 P2P P6G R.V RHF RHI RPM SJN TR2 TRP UHB W8F WOQ AAYXX CITATION 7QL 7QP 7T5 7TK 7U9 8FD C1K EMB FR3 H94 M7N P64 RC3 7X8 5PM .55 .GJ 0VX 3O- 9M8 ABXSW ADTPV AFFNX AI. AOWAS D8T DG8 EMOBN H~9 MK0 MVM N4W OHT OVD SV3 VH1 X7M ZGI ZZAVC |
ID | FETCH-LOGICAL-c516t-9b9e439b79755845622341e5b6fa81469e147faab0c10199fc872475ea55436b3 |
IEDL.DBID | RPM |
ISSN | 0022-1007 1540-9538 |
IngestDate | Sat Aug 24 00:47:17 EDT 2024 Tue Sep 17 21:23:53 EDT 2024 Sat Aug 17 00:10:46 EDT 2024 Wed Sep 25 02:46:27 EDT 2024 Fri Aug 23 00:56:37 EDT 2024 Tue Aug 27 13:46:23 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Language | English |
License | 2018 Ulrich et al. This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms/). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 International license, as described at https://creativecommons.org/licenses/by-nc-sa/4.0/). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c516t-9b9e439b79755845622341e5b6fa81469e147faab0c10199fc872475ea55436b3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 J.D. Ulrich, T.K. Ulland, and T.E. Mahan contributed equally to this paper. |
ORCID | 0000-0002-4303-4783 0000-0001-7964-7963 0000-0001-5222-4987 0000-0002-6608-4628 0000-0002-3400-0856 0000-0002-6507-4989 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5881464/ |
PMID | 29483128 |
PQID | 2020477245 |
PQPubID | 2046203 |
PageCount | 12 |
ParticipantIDs | swepub_primary_oai_DiVA_org_liu_150505 pubmedcentral_primary_oai_pubmedcentral_nih_gov_5881464 proquest_miscellaneous_2008885505 proquest_journals_2020477245 crossref_primary_10_1084_jem_20171265 pubmed_primary_29483128 |
PublicationCentury | 2000 |
PublicationDate | 20180402 |
PublicationDateYYYYMMDD | 2018-04-02 |
PublicationDate_xml | – month: 4 year: 2018 text: 20180402 day: 2 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: New York |
PublicationTitle | The Journal of experimental medicine |
PublicationTitleAlternate | J Exp Med |
PublicationYear | 2018 |
Publisher | Rockefeller University Press |
Publisher_xml | – name: Rockefeller University Press |
References | Wang (2023072604113442000_bib52) 2016; 213 Gutierrez (2023072604113442000_bib16) 1993; 47 Saito (2023072604113442000_bib40) 2014; 17 Serrano-Pozo (2023072604113442000_bib41) 2013; 72 Ulland (2023072604113442000_bib49) 2017; 170 Bales (2023072604113442000_bib4) 1999; 96 Jankowsky (2023072604113442000_bib24) 2004; 13 Uchihara (2023072604113442000_bib48) 1995; 195 Bell (2023072604113442000_bib6) 2012; 485 Zhao (2023072604113442000_bib56) 2018; 83 Liu (2023072604113442000_bib32) 2017; 96 Radde (2023072604113442000_bib38) 2006; 7 Grainger (2023072604113442000_bib13) 2004; 173 Magnusson (2023072604113442000_bib33) 2014; 8 Aguzzi (2023072604113442000_bib1) 2013; 339 Zhou (2023072604113442000_bib57) 1996; 149 Shi (2023072604113442000_bib42) 2017; 549 Butovsky (2023072604113442000_bib7) 2014; 17 Nyström (2023072604113442000_bib37) 2013; 8 Song (2023072604113442000_bib44) 2017; 13 Butovsky (2023072604113442000_bib8) 2015; 77 Jonsson (2023072604113442000_bib26) 2013; 368 Mauch (2023072604113442000_bib34) 2001; 294 Katsouri (2023072604113442000_bib27) 2011; 6 Jay (2023072604113442000_bib25) 2017; 37 Holtzman (2023072604113442000_bib19) 1999; 103 Yeh (2023072604113442000_bib53) 2016; 91 Bell (2023072604113442000_bib5) 2007; 27 Hafezi-Moghadam (2023072604113442000_bib17) 2007; 292 Holtzman (2023072604113442000_bib20) 2000; 47 Krasemann (2023072604113442000_bib31) 2017; 47 Bales (2023072604113442000_bib3) 1997; 17 Rodriguez (2023072604113442000_bib39) 2014; 11 Fagan (2023072604113442000_bib12) 2002; 9 Su (2023072604113442000_bib47) 2006; 172 Yuan (2023072604113442000_bib54) 2016; 90 Zenaro (2023072604113442000_bib55) 2015; 21 Klingstedt (2023072604113442000_bib30) 2013; 14 Keren-Shaul (2023072604113442000_bib28) 2017; 169 Huynh (2023072604113442000_bib22) 2017; 96 Griciuc (2023072604113442000_bib14) 2013; 78 Shin (2023072604113442000_bib43) 2014; 271 Chung (2023072604113442000_bib9) 2016; 113 Huynh (2023072604113442000_bib21) 2017; 58 Deane (2023072604113442000_bib11) 2008; 118 Guerreiro (2023072604113442000_bib15) 2013; 368 Atagi (2023072604113442000_bib2) 2015; 290 Irizarry (2023072604113442000_bib23) 2000; 100 Ulrich (2023072604113442000_bib50) 2014; 9 Heneka (2023072604113442000_bib18) 2015; 16 Condello (2023072604113442000_bib10) 2015; 6 Naj (2023072604113442000_bib36) 2011; 43 Musiek (2023072604113442000_bib35) 2015; 18 Klingstedt (2023072604113442000_bib29) 2011; 9 Styren (2023072604113442000_bib46) 2000; 48 Srinivasan (2023072604113442000_bib45) 2016; 7 Wang (2023072604113442000_bib51) 2015; 160 |
References_xml | – volume: 14 start-page: 607 year: 2013 ident: 2023072604113442000_bib30 article-title: Luminescent conjugated oligothiophenes for sensitive fluorescent assignment of protein inclusion bodies publication-title: ChemBioChem. doi: 10.1002/cbic.201200731 contributor: fullname: Klingstedt – volume: 485 start-page: 512 year: 2012 ident: 2023072604113442000_bib6 article-title: Apolipoprotein E controls cerebrovascular integrity via cyclophilin A publication-title: Nature. doi: 10.1038/nature11087 contributor: fullname: Bell – volume: 6 start-page: 6176 year: 2015 ident: 2023072604113442000_bib10 article-title: Microglia constitute a barrier that prevents neurotoxic protofibrillar Aβ42 hotspots around plaques publication-title: Nat. Commun. doi: 10.1038/ncomms7176 contributor: fullname: Condello – volume: 17 start-page: 661 year: 2014 ident: 2023072604113442000_bib40 article-title: Single App knock-in mouse models of Alzheimer’s disease publication-title: Nat. Neurosci. doi: 10.1038/nn.3697 contributor: fullname: Saito – volume: 48 start-page: 1223 year: 2000 ident: 2023072604113442000_bib46 article-title: X-34, a fluorescent derivative of Congo red: a novel histochemical stain for Alzheimer’s disease pathology publication-title: J. Histochem. Cytochem. doi: 10.1177/002215540004800906 contributor: fullname: Styren – volume: 118 start-page: 4002 year: 2008 ident: 2023072604113442000_bib11 article-title: apoE isoform-specific disruption of amyloid β peptide clearance from mouse brain publication-title: J. Clin. Invest. doi: 10.1172/JCI36663 contributor: fullname: Deane – volume: 339 start-page: 156 year: 2013 ident: 2023072604113442000_bib1 article-title: Microglia: scapegoat, saboteur, or something else? publication-title: Science. doi: 10.1126/science.1227901 contributor: fullname: Aguzzi – volume: 96 start-page: 1013 year: 2017 ident: 2023072604113442000_bib22 article-title: Age-Dependent Effects of apoE Reduction Using Antisense Oligonucleotides in a Model of β-amyloidosis publication-title: Neuron. doi: 10.1016/j.neuron.2017.11.014 contributor: fullname: Huynh – volume: 549 start-page: 523 year: 2017 ident: 2023072604113442000_bib42 article-title: ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy publication-title: Nature. doi: 10.1038/nature24016 contributor: fullname: Shi – volume: 27 start-page: 909 year: 2007 ident: 2023072604113442000_bib5 article-title: Transport pathways for clearance of human Alzheimer’s amyloid β-peptide and apolipoproteins E and J in the mouse central nervous system publication-title: J. Cereb. Blood Flow Metab. doi: 10.1038/sj.jcbfm.9600419 contributor: fullname: Bell – volume: 72 start-page: 462 year: 2013 ident: 2023072604113442000_bib41 article-title: Differential relationships of reactive astrocytes and microglia to fibrillar amyloid deposits in Alzheimer disease publication-title: J. Neuropathol. Exp. Neurol. doi: 10.1097/NEN.0b013e3182933788 contributor: fullname: Serrano-Pozo – volume: 83 start-page: 347 year: 2018 ident: 2023072604113442000_bib56 article-title: Apolipoprotein E, Receptors, and Modulation of Alzheimer’s Disease publication-title: Biol. Psychiatry. doi: 10.1016/j.biopsych.2017.03.003 contributor: fullname: Zhao – volume: 169 start-page: 1276 year: 2017 ident: 2023072604113442000_bib28 article-title: A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease publication-title: Cell. doi: 10.1016/j.cell.2017.05.018 contributor: fullname: Keren-Shaul – volume: 7 start-page: 11295 year: 2016 ident: 2023072604113442000_bib45 article-title: Untangling the brain’s neuroinflammatory and neurodegenerative transcriptional responses publication-title: Nat. Commun. doi: 10.1038/ncomms11295 contributor: fullname: Srinivasan – volume: 103 start-page: R15 year: 1999 ident: 2023072604113442000_bib19 article-title: Expression of human apolipoprotein E reduces amyloid-β deposition in a mouse model of Alzheimer’s disease publication-title: J. Clin. Invest. doi: 10.1172/JCI6179 contributor: fullname: Holtzman – volume: 9 start-page: 8356 year: 2011 ident: 2023072604113442000_bib29 article-title: Synthesis of a library of oligothiophenes and their utilization as fluorescent ligands for spectral assignment of protein aggregates publication-title: Org. Biomol. Chem. doi: 10.1039/c1ob05637a contributor: fullname: Klingstedt – volume: 11 start-page: 111 year: 2014 ident: 2023072604113442000_bib39 article-title: Human APOE4 increases microglia reactivity at Aβ plaques in a mouse model of Aβ deposition publication-title: J. Neuroinflammation. doi: 10.1186/1742-2094-11-111 contributor: fullname: Rodriguez – volume: 47 start-page: 739 year: 2000 ident: 2023072604113442000_bib20 article-title: Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer’s disease model publication-title: Ann. Neurol. doi: 10.1002/1531-8249(200006)47:6<739::AID-ANA6>3.0.CO;2-8 contributor: fullname: Holtzman – volume: 292 start-page: C1256 year: 2007 ident: 2023072604113442000_bib17 article-title: ApoE deficiency leads to a progressive age-dependent blood-brain barrier leakage publication-title: Am. J. Physiol. Cell Physiol. doi: 10.1152/ajpcell.00563.2005 contributor: fullname: Hafezi-Moghadam – volume: 9 start-page: 20 year: 2014 ident: 2023072604113442000_bib50 article-title: Altered microglial response to Aβ plaques in APPPS1-21 mice heterozygous for TREM2 publication-title: Mol. Neurodegener. doi: 10.1186/1750-1326-9-20 contributor: fullname: Ulrich – volume: 290 start-page: 26043 year: 2015 ident: 2023072604113442000_bib2 article-title: Apolipoprotein E Is a Ligand for Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) publication-title: J. Biol. Chem. doi: 10.1074/jbc.M115.679043 contributor: fullname: Atagi – volume: 170 start-page: 649 year: 2017 ident: 2023072604113442000_bib49 article-title: TREM2 Maintains Microglial Metabolic Fitness in Alzheimer’s Disease publication-title: Cell doi: 10.1016/j.cell.2017.07.023 contributor: fullname: Ulland – volume: 6 start-page: e21880 year: 2011 ident: 2023072604113442000_bib27 article-title: Lack of LDL receptor enhances amyloid deposition and decreases glial response in an Alzheimer’s disease mouse model publication-title: PLoS One. doi: 10.1371/journal.pone.0021880 contributor: fullname: Katsouri – volume: 43 start-page: 436 year: 2011 ident: 2023072604113442000_bib36 article-title: Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer’s disease publication-title: Nat. Genet. doi: 10.1038/ng.801 contributor: fullname: Naj – volume: 13 start-page: 159 year: 2004 ident: 2023072604113442000_bib24 article-title: Mutant presenilins specifically elevate the levels of the 42 residue β-amyloid peptide in vivo: evidence for augmentation of a 42-specific γ secretase publication-title: Hum. Mol. Genet. doi: 10.1093/hmg/ddh019 contributor: fullname: Jankowsky – volume: 149 start-page: 359 year: 1996 ident: 2023072604113442000_bib57 article-title: Evidence for a local immune response in atherosclerosis. CD4+ T cells infiltrate lesions of apolipoprotein-E-deficient mice publication-title: Am. J. Pathol. contributor: fullname: Zhou – volume: 78 start-page: 631 year: 2013 ident: 2023072604113442000_bib14 article-title: Alzheimer’s disease risk gene CD33 inhibits microglial uptake of amyloid beta publication-title: Neuron. doi: 10.1016/j.neuron.2013.04.014 contributor: fullname: Griciuc – volume: 13 start-page: 381 year: 2017 ident: 2023072604113442000_bib44 article-title: Alzheimer’s disease-associated TREM2 variants exhibit either decreased or increased ligand-dependent activation publication-title: Alzheimers Dement. doi: 10.1016/j.jalz.2016.07.004 contributor: fullname: Song – volume: 96 start-page: 15233 year: 1999 ident: 2023072604113442000_bib4 article-title: Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer’s disease publication-title: Proc. Natl. Acad. Sci. USA. doi: 10.1073/pnas.96.26.15233 contributor: fullname: Bales – volume: 7 start-page: 940 year: 2006 ident: 2023072604113442000_bib38 article-title: Abeta42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology publication-title: EMBO Rep. doi: 10.1038/sj.embor.7400784 contributor: fullname: Radde – volume: 47 start-page: 566 year: 2017 ident: 2023072604113442000_bib31 article-title: The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases publication-title: Immunity. doi: 10.1016/j.immuni.2017.08.008 contributor: fullname: Krasemann – volume: 172 start-page: 1799 year: 2006 ident: 2023072604113442000_bib47 article-title: Quantitative trait locus analysis of atherosclerosis in an intercross between C57BL/6 and C3H mice carrying the mutant apolipoprotein E gene publication-title: Genetics. doi: 10.1534/genetics.105.051912 contributor: fullname: Su – volume: 160 start-page: 1061 year: 2015 ident: 2023072604113442000_bib51 article-title: TREM2 lipid sensing sustains the microglial response in an Alzheimer’s disease model publication-title: Cell. doi: 10.1016/j.cell.2015.01.049 contributor: fullname: Wang – volume: 368 start-page: 117 year: 2013 ident: 2023072604113442000_bib15 article-title: TREM2 variants in Alzheimer’s disease publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1211851 contributor: fullname: Guerreiro – volume: 8 start-page: 1128 year: 2013 ident: 2023072604113442000_bib37 article-title: Evidence for age-dependent in vivo conformational rearrangement within Aβ amyloid deposits publication-title: ACS Chem. Biol. doi: 10.1021/cb4000376 contributor: fullname: Nyström – volume: 271 start-page: 8 year: 2014 ident: 2023072604113442000_bib43 article-title: Apolipoprotein E mediation of neuro-inflammation in a murine model of multiple sclerosis publication-title: J. Neuroimmunol. doi: 10.1016/j.jneuroim.2014.03.010 contributor: fullname: Shin – volume: 113 start-page: 10186 year: 2016 ident: 2023072604113442000_bib9 article-title: Novel allele-dependent role for APOE in controlling the rate of synapse pruning by astrocytes publication-title: Proc. Natl. Acad. Sci. USA. doi: 10.1073/pnas.1609896113 contributor: fullname: Chung – volume: 17 start-page: 131 year: 2014 ident: 2023072604113442000_bib7 article-title: Identification of a unique TGF-β-dependent molecular and functional signature in microglia publication-title: Nat. Neurosci. doi: 10.1038/nn.3599 contributor: fullname: Butovsky – volume: 47 start-page: 169 year: 1993 ident: 2023072604113442000_bib16 article-title: Murine tumor necrosis factor alpha is transported from blood to brain in the mouse publication-title: J. Neuroimmunol. doi: 10.1016/0165-5728(93)90027-V contributor: fullname: Gutierrez – volume: 294 start-page: 1354 year: 2001 ident: 2023072604113442000_bib34 article-title: CNS synaptogenesis promoted by glia-derived cholesterol publication-title: Science. doi: 10.1126/science.294.5545.1354 contributor: fullname: Mauch – volume: 18 start-page: 800 year: 2015 ident: 2023072604113442000_bib35 article-title: Three dimensions of the amyloid hypothesis: time, space and ‘wingmen’ publication-title: Nat. Neurosci. doi: 10.1038/nn.4018 contributor: fullname: Musiek – volume: 16 start-page: 229 year: 2015 ident: 2023072604113442000_bib18 article-title: Innate immunity in Alzheimer’s disease publication-title: Nat. Immunol. doi: 10.1038/ni.3102 contributor: fullname: Heneka – volume: 17 start-page: 263 year: 1997 ident: 2023072604113442000_bib3 article-title: Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition publication-title: Nat. Genet. doi: 10.1038/ng1197-263 contributor: fullname: Bales – volume: 96 start-page: 1024 year: 2017 ident: 2023072604113442000_bib32 article-title: ApoE4 Accelerates Early Seeding of Amyloid Pathology publication-title: Neuron. doi: 10.1016/j.neuron.2017.11.013 contributor: fullname: Liu – volume: 91 start-page: 328 year: 2016 ident: 2023072604113442000_bib53 article-title: TREM2 Binds to Apolipoproteins, Including APOE and CLU/APOJ, and Thereby Facilitates Uptake of Amyloid-Beta by Microglia publication-title: Neuron. doi: 10.1016/j.neuron.2016.06.015 contributor: fullname: Yeh – volume: 195 start-page: 5 year: 1995 ident: 2023072604113442000_bib48 article-title: ApoE immunoreactivity and microglial cells in Alzheimer’s disease brain publication-title: Neurosci. Lett. doi: 10.1016/0304-3940(95)11763-M contributor: fullname: Uchihara – volume: 8 start-page: 319 year: 2014 ident: 2023072604113442000_bib33 article-title: Multimodal fluorescence microscopy of prion strain specific PrP deposits stained by thiophene-based amyloid ligands publication-title: Prion. doi: 10.4161/pri.29239 contributor: fullname: Magnusson – volume: 368 start-page: 107 year: 2013 ident: 2023072604113442000_bib26 article-title: Variant of TREM2 associated with the risk of Alzheimer’s disease publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1211103 contributor: fullname: Jonsson – volume: 21 start-page: 880 year: 2015 ident: 2023072604113442000_bib55 article-title: Neutrophils promote Alzheimer’s disease-like pathology and cognitive decline via LFA-1 integrin publication-title: Nat. Med. doi: 10.1038/nm.3913 contributor: fullname: Zenaro – volume: 100 start-page: 451 year: 2000 ident: 2023072604113442000_bib23 article-title: Apolipoprotein E affects the amount, form, and anatomical distribution of amyloid beta-peptide deposition in homozygous APP(V717F) transgenic mice publication-title: Acta Neuropathol. doi: 10.1007/s004010000263 contributor: fullname: Irizarry – volume: 9 start-page: 305 year: 2002 ident: 2023072604113442000_bib12 article-title: Human and murine ApoE markedly alters A β metabolism before and after plaque formation in a mouse model of Alzheimer’s disease publication-title: Neurobiol. Dis. doi: 10.1006/nbdi.2002.0483 contributor: fullname: Fagan – volume: 90 start-page: 724 year: 2016 ident: 2023072604113442000_bib54 article-title: TREM2 Haplodeficiency in Mice and Humans Impairs the Microglia Barrier Function Leading to Decreased Amyloid Compaction and Severe Axonal Dystrophy publication-title: Neuron. doi: 10.1016/j.neuron.2016.05.003 contributor: fullname: Yuan – volume: 77 start-page: 75 year: 2015 ident: 2023072604113442000_bib8 article-title: Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice publication-title: Ann. Neurol. doi: 10.1002/ana.24304 contributor: fullname: Butovsky – volume: 173 start-page: 6366 year: 2004 ident: 2023072604113442000_bib13 article-title: Apolipoprotein E modulates clearance of apoptotic bodies in vitro and in vivo, resulting in a systemic proinflammatory state in apolipoprotein E-deficient mice publication-title: J. Immunol. doi: 10.4049/jimmunol.173.10.6366 contributor: fullname: Grainger – volume: 37 start-page: 637 year: 2017 ident: 2023072604113442000_bib25 article-title: Disease progression-dependent effects of TREM2 deficiency in a mouse model of Alzheimer’s disease publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.2110-16.2016 contributor: fullname: Jay – volume: 213 start-page: 667 year: 2016 ident: 2023072604113442000_bib52 article-title: TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques publication-title: J. Exp. Med. doi: 10.1084/jem.20151948 contributor: fullname: Wang – volume: 58 start-page: 824 year: 2017 ident: 2023072604113442000_bib21 article-title: Apolipoprotein E and Alzheimer’s disease: The influence of apolipoprotein E on amyloid-β and other amyloidogenic proteins publication-title: J. Lipid Res. doi: 10.1194/jlr.R075481 contributor: fullname: Huynh |
SSID | ssj0014456 |
Score | 2.6418855 |
Snippet | One of the hallmarks of Alzheimer's disease is the presence of extracellular diffuse and fibrillar plaques predominantly consisting of the amyloid-β (Aβ)... One of the hallmarks of Alzheimer’s disease is the presence of extracellular diffuse and fibrillar plaques predominantly consisting of the amyloid-β (Aβ)... Increasing evidence suggests that apoE influences the innate immune response in neurodegeneration. Here, Ulrich et al. report that apoE influences amyloid... One of the hallmarks of Alzheimers disease is the presence of extracellular diffuse and fibrillar plaques predominantly consisting of the amyloid-beta (A beta)... |
SourceID | swepub pubmedcentral proquest crossref pubmed |
SourceType | Open Access Repository Aggregation Database Index Database |
StartPage | 1047 |
SubjectTerms | Apolipoprotein E Axons Brain Deposition Fluorescence Fluoroscopic imaging Gene expression Immune clearance Immune response Immune system Innate immunity Metabolism Mice Neurodegeneration Neurodegenerative diseases Neuroimaging Neurological diseases Neurotoxicity Pathology Reduction Rodents Senile plaques Toxicity Transgenic mice β-Amyloid |
Title | ApoE facilitates the microglial response to amyloid plaque pathology |
URI | https://www.ncbi.nlm.nih.gov/pubmed/29483128 https://www.proquest.com/docview/2020477245/abstract/ https://search.proquest.com/docview/2008885505 https://pubmed.ncbi.nlm.nih.gov/PMC5881464 https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-150505 |
Volume | 215 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB6SHEIvpWn62DYtCrS9OWvrYUnHJQ9CYEsPTcnNSFopddi1l338_45ke8mSW_FxZCQ-jdAnzacZgG9hpoVigWaUSjygyHyWaRp4prVnznkWRMp4M_1Z3t7zuwfxcABieAuTRPvO1hfNfHHR1H-TtnK5cONBJzb-Nb0UKl5c8fEhHErGhiN6HzrgPJVsTTL1KAHo1e654uMnH9-eF7KgZaxYQzVXrIh12J9vSS945ku55F5S0bQR3byB1z2DJJNupCdw4Ju3cDztY-SncDVZttckGNfl3_ZrghyPLKLw7nGO3kZWnSzWk01LzAIP7PWMLOcGh0NifeJ0z_4O7m-uf1_eZn2thMyJotxk2mqP3MJKLQVyCmQ1FPcnL2wZTARL-4LLYIzNHS5CrYNTknIpvEE-wUrL3sNR0zb-IxCLqzKIMAsuZ9w7q0RgNjBuTWlySekIvg9wVcsuJUaVQtmKV4hwNSA8grMBy6pfGGs00pwjo-doPt-Z0aVjnMI0vt2uU2VMFROtYZsPHfS7joY5G4Hcm5Rdg5gue9-CXpTSZvdeM4If3fTt_XJV_5lU7eqxmtfbCkkyfp_-u4vP8ApBUEngQ8_gaLPa-i_IXTb2a_LVf-pG7d4 |
link.rule.ids | 230,315,733,786,790,891,27957,27958,53827,53829 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwEB4tiwRceD8KCxgJuKVNHDuOj9U-VGC74rC72ltku_ZSSJOqTQ_w6xk7SUXZEyjHceQ445E_ez5_A_DezSTPU0cjSgVuUEQ8iyR1LJLSpsbY1PGgeDM9yyYX7PMVv9oD3t-FCaR9o-fDqlwMq_m3wK1cLsyo54mNvk4Pee4PrtjoFtzGeKWi36R3yQPGQtHWQFT3JICO7x7nbPTd-tvniUho5mvWUMnyNPGV2P9clG4gzZuEyR1Z0bAUnTyAy34QLQPlx3DT6KH59Ze-4z-P8iHc78ApGbfmR7Bnq8dwZ9ql35_A0XhZHxOnTCvtbdcE4SNZeE7fdYkTmaxaxq0lTU3U4mdZz2dkWSocJ_Glj8MR_lO4ODk-P5xEXRmGyPAkayKppUXYooUUHOEKAiaKS5_lOnPKf6G0CRNOKR0bjG8pnckFZYJbhVAlzXT6DParurIvgGgMeMfdzJk4ZdbonLtUu5RplalYUDqAD70fimWrtlGELHnOCnRd0btuAAe9k4ou5tZopDHDzQJD87utGaPFp0BUZevNOhTdzL2GG7Z53vp021E_GQYgdry9beCVuHct6LqgyN25agAf23mx88rR_HJc1KvropxvCsTf-Lz87y7ewt3J-fS0OP109uUV3MMfkgceET2A_Wa1sa8RIjX6TQiI38ceD-k |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Pb9MwGLVgSBMXfjM6BhgJuKVJHDuOj9W6avzotANDE5fIduxRliZRmx7gr-ezk1Qru0052pHjPH_yc76X9yH0wRaCZYklASEcDig8KgJBLA2EMInWJrHMO97Mz9LTC_rlkl3eKPXlRftaLcZVuRxXi19eW9ksdTjoxMLz-THL3IcrGjaFDe-jBxCzRAwH9T6BQKkv3OrF6k4I0Gveo4yGv437Az3mMUld3RoiaJbErhr7zY3pFtu8LZrcsRb129HsMfo5TKRToVyPN60a67__eTzeaaZP0KOepOJJ1-UpumeqZ2h_3qfhn6PppKlPsJW6s_g2aww0Ei-dtu-qhAWNV53y1uC2xnL5p6wXBW5KCXPFrgSy_5T_Al3MTr4fnwZ9OYZAszhtA6GEAfqiuOAMaAsQJwJboGEqtdI9pTAx5VZKFWmIcyGszjihnBkJlCVJVfIS7VV1ZV4hrCDwLbOF1VFCjVYZs4myCVUylREnZIQ-DljkTee6kftseUZzgC8f4BuhowGovI-9NTSSiMKhgULz-20zRI1LhcjK1Ju1L76ZOS836HPQ4bodaFgQI8R3EN92cI7cuy0An3fm7uEaoU_d2ti5Zbr4Mcnr1VVeLjY58HC4Du88xDu0fz6d5d8-n319jR7C-8i8nIgcob12tTFvgCm16q2PiX9PphJp |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=ApoE+facilitates+the+microglial+response+to+amyloid+plaque+pathology&rft.jtitle=The+Journal+of+experimental+medicine&rft.au=Ulrich%2C+Jason+D.&rft.au=Ulland%2C+Tyler+K.&rft.au=Mahan%2C+Thomas+E.&rft.au=Nystr%C3%B6m%2C+Sofie&rft.date=2018-04-02&rft.pub=Rockefeller+University+Press&rft.issn=0022-1007&rft.eissn=1540-9538&rft.volume=215&rft.issue=4&rft.spage=1047&rft.epage=1058&rft_id=info:doi/10.1084%2Fjem.20171265&rft_id=info%3Apmid%2F29483128&rft.externalDBID=PMC5881464 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-1007&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-1007&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-1007&client=summon |